Rifampicin in the treatment of tuberculous meningitis. 1978

N I Girgis, and M W Yassin, and L W Laughlin, and D C Edman, and Z Farid, and R H Watten

Seventy-one patients diagnosed to have tuberculous meningitis were treated with isoniazid, streptomycin plus either rifampicin (36 patients or ethambutol (35 patients). Results of therapy were identical in both treatment-groups (approximately 50 per cent mortality). Rifampicin appears to be as effective as ethambutol in the treatment of this infection.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004977 Ethambutol An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. (From Smith and Reynard, Textbook of Pharmacology, 1992, p863) Dexambutol,EMB-Fatol,EMB-Hefa,Etambutol Llorente,Ethambutol Hydrochloride,Etibi,Miambutol,Myambutol,EMB Fatol,EMB Hefa,Hydrochloride, Ethambutol,Llorente, Etambutol
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

N I Girgis, and M W Yassin, and L W Laughlin, and D C Edman, and Z Farid, and R H Watten
December 1970, El Torax,
N I Girgis, and M W Yassin, and L W Laughlin, and D C Edman, and Z Farid, and R H Watten
January 1985, Revista latinoamericana de microbiologia,
N I Girgis, and M W Yassin, and L W Laughlin, and D C Edman, and Z Farid, and R H Watten
December 1975, The Journal of pediatrics,
N I Girgis, and M W Yassin, and L W Laughlin, and D C Edman, and Z Farid, and R H Watten
January 2013, The Lancet. Infectious diseases,
N I Girgis, and M W Yassin, and L W Laughlin, and D C Edman, and Z Farid, and R H Watten
July 2013, The Lancet. Infectious diseases,
N I Girgis, and M W Yassin, and L W Laughlin, and D C Edman, and Z Farid, and R H Watten
July 2013, The Lancet. Infectious diseases,
N I Girgis, and M W Yassin, and L W Laughlin, and D C Edman, and Z Farid, and R H Watten
January 1984, European journal of clinical pharmacology,
N I Girgis, and M W Yassin, and L W Laughlin, and D C Edman, and Z Farid, and R H Watten
December 1981, Anales espanoles de pediatria,
N I Girgis, and M W Yassin, and L W Laughlin, and D C Edman, and Z Farid, and R H Watten
October 1973, Wiener klinische Wochenschrift,
N I Girgis, and M W Yassin, and L W Laughlin, and D C Edman, and Z Farid, and R H Watten
May 1972, Lyon medical,
Copied contents to your clipboard!